ArticleNeuro-oncology2021

Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients.

Emily J Tonogai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.